Cargando...
Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer’s disease biomarker candidates
There is significant interest in the development of methods to validate novel biomarkers for Alzheimer’s disease (AD) diagnosis. Previously, a proteomic panel of cerebrospinal fluid (CSF) biomarker candidates that differentiated AD and non-AD CSF with accuracy higher than 90% was found; information...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3710693/ https://ncbi.nlm.nih.gov/pubmed/23735279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchromb.2013.05.003 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|